510(k) Report

510(k) · Cleared

Cleared

Denver Ascites Shunt and Percutaneous Access Kit with Ascities Shunt

K011862510(k) SpecialCleared Jul 12, 200128-day reviewClass II21 CFR 876.5955

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Denver Biomedical, Inc. · KPM Shunt, Peritoneal

Cleared on Jul 12, 2001 after a 28-day review. The FDA summary names no predicate by number. 1 later device descends from it.

Decided
Jul 12, 2001
Review
28 days
Class
Class II
Product code
KPM
Recalls
None
Predicates
0

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2017: 1 descendant cleared200020052010201520202025
  1. This deviceK011862 Denver Ascites Shunt and Percutaneous Access Kit with Ascities ShuntDenver Biomedical, Inc. · 2001
  2. Descendant · cites it directly · 0 of its ownK170405 BD Curve Ascites ShuntCare Fusion · 2017

Most influential descendants

Showing 1 of 1 · See all
  • K170405BD Curve Ascites ShuntCare Fusion · 2017 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K011862Denver Ascites Shunt and Percutaneous Access Kit with Ascities ShuntDenver Biomedical, Inc.2001—
+1K170405BD Curve Ascites ShuntCare Fusion2017—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201710
FIG. 1 — Lineage of K011862, 2001–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KPM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KPM device

  1. #1 K231096 Automatic Continuous Effusion Shunt (ACES)…score 5.9 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K170405BD Curve Ascites ShuntCare Fusion20170

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K170405 (Care Fusion, 2017) has gone furthest, with 0 descendants of its own.

How does its category compare?

All KPM devices

KPM Shunt, Peritoneal: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KPM

1in 2023

2017: 12023: 1
2007high 1 (2017) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KPM

Too few KPM 510(k)s in any year since 2007 to give a median.

Recalls per year · KPM

No recall names KPM since 2007.

Adverse event reports per year · KPM

1in 2025

2007: 22008: 32009: 12010: 12011: 12012: 12013: 682014: 12017: 22022: 22023: 12024: 42025: 1
2007high 68 (2013) · low 0 (2015)2025

MAUDE reports naming product code KPM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—02
20080—03
20090—01
20100—01
20110—01
20120—01
20130—068
20140—01
20150—00
20160—00
20171—02
20180—00
20190—00
20200—00
20210—00
20220—02
20231—01
20240—04
20250—01
20260—0—

What is it indicated for?

Peritoneo-venous shunting is indicated for patients with:

. chronic liver disease whose ascites has not responded to surgical correction of their

portal hypertension nor to standard medical management.

. persistent ascites who are not considered candidates for portal-venous shunting.

. persistent ascites that is non-responsive to standard medical management..

. primary or metastatic intra-abdominal neoplasms with massive ascites to help relieve

intra-abdominal pressure.

Peritoneo-venous shunting should also be considered for patients with hepatorenal

syndrome, chylous ascites and idiopathic ascites.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K011862: Denver Ascites Shunt and Percutaneous Access Kit with Ascities Shunt.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K011862

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026